From the media


Domenica, 03 Aprile 2022

The T-REM3DIE (Tendon REpair MEdical DevIcE) project deals with the development of an innovative system for tendon repair. Based on a resorbable device and a dedicated applicator, the material of the device, biocompatible and bioabsorbable, ensures both the necessary resistance in the tissue regeneration phase and the subsequent degradation of the material with predictable timing in line with the rehabilitation process. Savings in costs for the healthcare system, as well as accelerates healing for patients are the main gains of the project. Veterinary field and human are the two target markets, the first being easier to reach while the latter larger in terms of impact and value.


Investing in Technology Readiness Levels (TRL) ranging from 3 to 5 requires a careful assessment of the potential of the technology and the team. Due to the low maturity of these projects, these projects require a de-risking process to be carried out directly at the University and Research Center. Eureka! TT S.r.l. is the Italian limited responsibility company fully owned by “Eureka! Fund I – Technology Transfer that acts on behalf of the Fund, in providing financial resources to the pre-company, Proof-of-Concept (“POC”) projects, as well as in monitoring the advancement and the results of such investments.

The resources provided by Eureka! are given to the University and Research Center, in order to develop the technology, increase TRL and support the team of the “to-be entrepreneurs” in proving their ideas are sustainable. Successful projects will be then span-out into new start-ups. Eureka! TT can effectively bridge the gap between the need for a market-driven test and a University-like environment.

Published in Eureka! Fund I